Azitra (AZTR) had the highest return between April 1, 2023 and October 31, 2023 by a US stock, returning 5,357,042.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Azitra (AZTR) | 4/1/2023 - 10/31/2023 | 5,357,042.86% |
Foremost Lithium Resource & Technology Ltd Common stock (FMST) | 4/1/2023 - 10/31/2023 | 101,900% |
Lottery (SEGG) | 4/1/2023 - 10/31/2023 | 6,928.99% |
Soleno Therapeutics (SLNO) | 4/1/2023 - 10/31/2023 | 1,035.71% |
Eightco (OCTO) | 4/1/2023 - 10/31/2023 | 485.54% |
enGene Holdings Inc Warrants (ENGNW) | 4/1/2023 - 10/31/2023 | 428.19% |
ICZOOM Group Inc Class A Ordinary Shares (IZM) | 4/1/2023 - 10/31/2023 | 398.82% |
X3 (XTKG) | 4/1/2023 - 10/31/2023 | 377.51% |
FingerMotion (FNGR) | 4/1/2023 - 10/31/2023 | 285.81% |
Olema Pharmaceuticals (OLMA) | 4/1/2023 - 10/31/2023 | 278.63% |
LifeMD (LFMD) | 4/1/2023 - 10/31/2023 | 274.85% |
Cardlytics (CDLX) | 4/1/2023 - 10/31/2023 | 269.85% |
Applied Opt (AAOI) | 4/1/2023 - 10/31/2023 | 247.2% |
Bioventus (BVS) | 4/1/2023 - 10/31/2023 | 242.2% |
Golden Heaven Group Holdings Ltd Ordinary Shares (GDHG) | 4/1/2023 - 10/31/2023 | 238.75% |
Akso Health Group ADR (AHG) | 4/1/2023 - 10/31/2023 | 237.33% |
Marker Therapeutics (MRKR) | 4/1/2023 - 10/31/2023 | 228.77% |
error (ZVZZT) | 4/1/2023 - 10/31/2023 | 220% |
Renovaro Biosciences (RENB) | 4/1/2023 - 10/31/2023 | 219.96% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 4/1/2023 - 10/31/2023 | 219.3% |
US GoldMining Inc Warrant (USGOW) | 4/1/2023 - 10/31/2023 | 216.82% |
Groupon (GRPN) | 4/1/2023 - 10/31/2023 | 203.08% |
InspireMD (NSPR) | 4/1/2023 - 10/31/2023 | 200% |
Applied Therapeutics (APLT) | 4/1/2023 - 10/31/2023 | 200% |
Minerva Neurosciences (NERV) | 4/1/2023 - 10/31/2023 | 193.9% |
